Probiotics

Documents:
- Health benefits and health claims of probiotics: bridging science and marketing (JAN2012)
- EFFCA position on Probiotics (DEC2011)
- EFFCA statement following the publication of the second batch of EFSA scientific opinions on probiotics
- EFSA 2 December 2010 stakeholders meeting in Amsterdam: microbial food cultures industry welcome the initiative and request pre-submission consultation
Probiotics: the basis for the substantiation of gut and immune health
Scientific workshop organised by EFFCA and LABIP on 24 March 2010 in Brussels.
A debate among the scientific community on the data required to establish a probiotic health benefit claim is currently taking place. The objective of the workshop was to provide a “practical guide” for those involved in the scientific substantiation of probiotic health claims used in the EU. This workshop has confirmed that, even though there is not always consensus on the relation of immune parameters to general health or how to maintain the normal situation in the intestinal tract, there is a large number of excellent human studies that warrant substantiating specific gut or immune health claims for probiotics. Therefore, we must secure that these scientific findings are acknowledged in the EU regulations..
Video Highlights
Introduction by Mr Knud Vindfeldt, President of EFFCA
Introduction by Dr Jan Sikkema
Current state of play on what can be found in the literature today
Pr Ger Rijkers
Pr Lorenzo Morelli
Pr Robert-Jan Brummer
Q&A Session
Example of specific immune health benefits (end points, biomarkers)
Pr Ger Rijkers
Pr Eric Claassen
Q&A Session
How to demonstrate beneficial effects in healthy populations?
Pr Lorenzo Morelli
Conclusion by Mr Esben Laulund, Chairman of the steering Committee of LABIP
